In this conversation, we highlight a record-breaking 2025 for MTM within the Outcomes network, with 11.6M completed claims, growing pharmacist and technician engagement, and over $190M in clinical revenue generated.

But what’s most interesting isn’t just the growth, it’s the shift. We’re seeing movement beyond traditional CMRs toward adherence-driven programs, longitudinal patient engagement, and expanded clinical services like A1C and blood pressure monitoring.

Looking ahead, changes tied to CMS ratings in 2027 will bring renewed focus (and volume) to CMRs, making now the time for pharmacies to rethink workflows, staffing models, and technology investments.

The takeaway: MTM isn’t static. It’s evolving and pharmacies that plan for what’s next will be best positioned to capture both clinical and financial impact.

Shane reflects on his years supporting Medicare performance programs and draws parallels between the two sectors—especially around how HRAs have shifted from simple “check‑the‑box” tasks to powerful tools that uncover transportation barriers, food insecurity, medication access challenges, utility instability, and more.

Together, they explore:

• Why SDOH data is only valuable when it leads to meaningful action
• How community pharmacies—as trusted, accessible care touchpoints—are uniquely positioned to conduct sensitive assessments
• The growing importance of rural health transformation and how pharmacies can close engagement and adherence gaps
• How Outcomes is supporting pharmacies with technology, workflows, and scalable programs that enable efficient, person-to-person care
• What the future may hold as Medicaid and Medicare strategies continue to evolve

If you’re passionate about healthcare innovation, population health, or the expanding role of pharmacy, this conversation is packed with real-world insights you won’t want to miss.

He explores why MTM remains essential—not just for patient care, but for the financial sustainability of today’s pharmacies. He discusses the shifting landscape where dispensing margins have eroded, clinical services have become the new value driver, and yet emotional and historical frustrations with payers may be holding some pharmacists back from embracing what’s next.

Drawing on conversations with industry leaders and his own lived experience as an independent pharmacist, Jon challenges listeners to re‑examine assumptions, recognize cognitive biases, and reconnect with the shared goals of insurers, pharmacies, and patients.

Whether you're a chain pharmacist, an independent owner, or someone trying to understand the future of clinical care, this episode offers a grounded, honest look at where MTM stands—and where it needs to go next.